Amalgamated Bank’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
GS
Amalgamated Bank's RCUS Position: Q2 2026 in Review
Amalgamated Bank reduced its Arcus Biosciences (RCUS) stake by 3.4% in Q2 2026, selling an estimated $20.5K and leaving 23,384 shares worth $721K. The position accounts for 0.01% of the portfolio, ranked #1243.
Amalgamated Bank first reported a position in RCUS in Q3 2021 and has held it in 20 quarters since. 75 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.
- Amalgamated Bank held 23,384 shares of Arcus Biosciences worth $721K as of Q2 2026.
- Amalgamated Bank sold 830 Arcus Biosciences shares in Q2 2026, an estimated $20.5K.
- Arcus Biosciences made up 0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1243 holding.
- Amalgamated Bank first reported a position in Arcus Biosciences in Q3 2021 and has held it in 20 quarters since.
- 75 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.